A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
The Nurses’ Health Study shows that regular exercise and dietary changes can help some patients avoid medication for gastroesophageal reflux disease.
New research has found a novel plasmid associated with ulcerative colitis, but it is unclear if the molecule is a marker of the disease.
Best practice statements help to guide decision-making in diagnosis, surveillance, and treatment of ulcerative colitis and Crohn disease among patients aged 60 years and older.
The U.S. Food and Drug Administration cleared the EndoRotor System as a viable option to surgery for patients with walled-off pancreatic necrosis, with a boxed warning against use in suspected cases of pancreatic cancer.
Patients with ulcerative colitis in remission may be more likely to experience moderate to severe levels of fatigue and lack of productivity under certain conditions.
The American College of Gastroenterology has developed a clinical guideline for managing irritable bowel syndrome that addresses 25 key questions based on the strength and quality of evidence from medical literature.
Clearly communicating the findings of endoscopy to pathologists, colleagues, and patients requires some standardization in the preparation of endoscopic reports, David T. Rubin, MD, told the attendees of the Advances in Inflammatory Bowel Diseases 2020 virtual meeting on December 11.
Anne Griffiths, MD, of the Hospital for Sick Children in Toronto, spoke to the Advances in Inflammatory Bowel Diseases 2020 virtual meeting on research published this year into the special considerations involved in caring for children with Crohn disease and ulcerative colitis.
Updates to the SECURE-IBD international registry indicate that thiopurines and combination therapies may place patients with inflammatory bowel disease at heightened risk of poor outcomes from COVID-19, while anti-tumor necrosis factor agents may be protective.